The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
After finishing at $20.83 in the prior trading day, Beam Therapeutics Inc (NASDAQ: BEAM) closed at $19.93, down -4.32%. In other words, the price has decreased by -$4.32 from its previous closing price. On the day, 1.89 million shares were traded. BEAM stock price reached its highest trading level at $21.0745 during the session, while it also had its lowest trading level at $19.9.
Ratios:
Our goal is to gain a better understanding of BEAM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.81 and its Current Ratio is at 8.81. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On March 10, 2025, Scotiabank Upgraded its rating to Sector Outperform which previously was Sector Perform but kept the price unchanged to $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 03 ’25 when Simon Amy sold 876 shares for $20.12 per share. The transaction valued at 17,625 led to the insider holds 64,864 shares of the business.
Simon Amy sold 374 shares of BEAM for $6,336 on Jul 01 ’25. The Chief Medical Officer now owns 65,740 shares after completing the transaction at $16.94 per share. On Apr 01 ’25, another insider, Bellon Christine, who serves as the Chief Legal Officer of the company, sold 5,674 shares for $18.35 each. As a result, the insider received 104,122 and left with 117,294 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BEAM now has a Market Capitalization of 2004100992 and an Enterprise Value of 881077184. For the stock, the TTM Price-to-Sale (P/S) ratio is 31.52 while its Price-to-Book (P/B) ratio in mrq is 1.78. Its current Enterprise Value per Revenue stands at 13.858 whereas that against EBITDA is -2.156.
Stock Price History:
The Beta on a monthly basis for BEAM is 2.24, which has changed by -0.37010115 over the last 52 weeks, in comparison to a change of 0.15366066 over the same period for the S&P500. Over the past 52 weeks, BEAM has reached a high of $35.25, while it has fallen to a 52-week low of $13.52. The 50-Day Moving Average of the stock is 7.68%, while the 200-Day Moving Average is calculated to be -12.52%.
Shares Statistics:
The stock has traded on average 2.11M shares per day over the past 3-months and 2178040 shares per day over the last 10 days, according to various share statistics. A total of 100.56M shares are outstanding, with a floating share count of 89.78M. Insiders hold about 10.71% of the company’s shares, while institutions hold 88.16% stake in the company. Shares short for BEAM as of 1752537600 were 23661756 with a Short Ratio of 11.21, compared to 1749772800 on 21731372. Therefore, it implies a Short% of Shares Outstanding of 23661756 and a Short% of Float of 26.459998000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
